BD™ Cytometric Bead Array (CBA) Human IFN-α Standard

The Human IFN-α Standard has been tested to assure to function as a standard when used with the BD™ Cytometric Bead Array (CBA). Investigators are encouraged to refer to the technical data sheet for the BD™ CBA Human IFN-α Flex Set. The IFN-α Standard is lyophilized and should be reconstituted and serially diluted before mixing with CBA capture beads and PE detection reagents. An abbreviated instruction has been provided below (Preparation of Human IL-10 Standard Protocol). The Human IFN-α Standard should be reconstituted using Assay Diluent, which is provided with the BD™ CBA Human Soluble Protein Master Buffer Kit (Cat. No. 558264 or 558265) or it may also be purchased separately (BD™ Cytometric Bead Array (CBA) Assay Diluent; Cat. No. 560104).

Preparation of Human IFN-α Standard for use with the BD™ CBA Human IFN-α Flex Set (Cat. No. 560379):

1. Open one vial of the lyophilized Human IFN-α Standard. Transfer the lyosphere(s) to a polypropylene tube. Label the tube "Top Standard."

2. Reconstitute the standard with 4.0 mL of Assay Diluent. Allow the reconstituted standard to equilibrate for at least 15 minutes before making dilutions. Mix the reconstituted protein by pipette only. Do not vortex or mix vigorously.

3. Label additional 12 x 75 mm tubes and arrange them in the following order: Top Standard, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, 1:128, and 1:256.

4. Add 500 µl of Assay Diluent to each of the dilution tubes.

5. Perform a serial dilution by transferring 500 µl from the Top Standard to the 1:2 dilution tube and mix thoroughly. Do not vortex, mix by pipet only. Continue making serial dilutions by transferring 500 µl from the 1:2 tube to the 1:4 tube and so on to the 1:256 tube and mix thoroughly. Prepare one tube containing only Assay Diluent to serve as the 0 pg/mL negative control.

1. ProClin is a trademark of Rohm and Haas Company.
2. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
3. Warning: CBA lyophilized standard contains 0.02% (w/w) and Detection Reagent (Part A) contains 0.002% (w/w) of a CMIT/MIT mixture (3:1), which is a mixture of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC No 247-500-7] and 2-methyl-4-isothiazolin-3-one [EC No 220-239-6] (3:1).Hazard statement: May cause an allergic skin reaction.Precautionary statements: Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/eye/face protection. Wear protective clothing. Avoid breathing mist/vapours/spray. If skin irritation or rash occurs: Get medical advice/attention. IF ON SKIN: Wash with plenty of water. Take off contaminated clothing and wash it before reuse. Dispose of contents/container in accordance with local/regional/national/international regulations.
4. Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
5. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
6. Hazardous Ingredient: ProClin™ 150. Avoid exposure to skin and eyes and ingestion. Wash exposed skin with soap and water. Flush eyes with water.